Retail & Wholesale » Retail | Wanjia Group Holdings Ltd.

Wanjia Group Holdings Ltd. | Income Statement

Fiscal year is April-March. All values HKD Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
2,096
1,568
1,322
986
616
96
Cost of Goods Sold (COGS) incl. D&A
1,907
1,408
1,176
860
516
80
Gross Income
189
160
146
126
101
16
SG&A Expense
117
137
148
140
139
24
EBIT
73
23
2
13
38
8
Unusual Expense
-
785
785
-
2
35
Non Operating Income/Expense
-
7
5
6
3
-
Interest Expense
6
9
16
14
15
13
Pretax Income
74
765
12
24
51
56
Income Tax
25
8
1
1
5
2
Consolidated Net Income
49
773
13
26
55
58
Net Income
49
773
14
26
56
59
Net Income After Extraordinaries
49
773
14
26
56
52
Net Income Available to Common
49
773
14
26
56
72
EPS (Basic)
0.08
1.19
0.02
0.04
0.09
0.09
Basic Shares Outstanding
648
648
648
648
648
709
EPS (Diluted)
0.08
1.19
0.02
0.04
0.09
0.09
Diluted Shares Outstanding
648
648
648
648
648
709
EBITDA
77
28
4
7
29
3
Non-Operating Interest Income
-
1
-
1
1
-
Minority Interest Expense
-
-
-
-
-
1

About Wanjia Group Holdings

View Profile
Address
Room 1902, 19th Floor
Hong Kong
Hong Kong
Employees -
Website http://www.wanjia-gp.com
Updated 07/08/2019
Wanjia Group Holdings Ltd. wholesales and distributes pharmaceutical and healthcare products. It operates through following segments: Pharmaceutical Wholesale and Distribution Business; Pharmaceutical Retail Chain Business; and Hemodialysis Treatment and Consultancy Service Business. The Pharmaceutical Wholesale and Distribution Business segment provides wholesale and distribution, logistics, and other services for a range of pharmaceutical products of domestic manufacturers and other suppliers.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.